Intas Pharmaceuticals Ltd:企業の戦略的SWOT分析

◆英語タイトル:Intas Pharmaceuticals Ltd - Strategic SWOT Analysis Review
◆商品コード:GDPH91416SA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Intas Pharmaceuticals Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Intas Pharmaceuticals Ltd (Intas) develops, manufactures, and markets pharmaceuticals and biotechnology products for the treatment of a wide range of diseases and disorders in various therapeutic segments. The company offers products such as sevelamer, ciprofloxacin, amitryptyline, erythropoietin, filgrastim, follicle stimulating hormone (FSH), rituximab, ampicillin, albendazole, benezepril, and caprofen, among others. It also develops recombinant DNA protein (rDNA) products and plasma derived products for oncology, auto-immune, ophthalmology, nephrology and plasma derived product based therapies. It has formulation manufacturing facilities and active pharmaceutical ingredient (API) and intermediate facilities in India. The company markets products through internal sales force and a network of distributors worldwide. Intas is headquartered in Ahmedabad, Gujarat, India.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Intas Pharmaceuticals Ltd – Key Facts
Intas Pharmaceuticals Ltd – Key Employees
Intas Pharmaceuticals Ltd – Major Products and Services
Intas Pharmaceuticals Ltd – History
Intas Pharmaceuticals Ltd – Company Statement
Intas Pharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Intas Pharmaceuticals Ltd – Business Description
Intas Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Intas Pharmaceuticals Ltd – Strengths
Intas Pharmaceuticals Ltd – Weaknesses
Intas Pharmaceuticals Ltd – Opportunities
Intas Pharmaceuticals Ltd – Threats
Intas Pharmaceuticals Ltd – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Intas Pharmaceuticals Ltd, Key Facts
Intas Pharmaceuticals Ltd, Key Employees
Intas Pharmaceuticals Ltd, Major Products and Services
Intas Pharmaceuticals Ltd, History
Intas Pharmaceuticals Ltd, Other Locations
Intas Pharmaceuticals Ltd, Subsidiaries
Intas Pharmaceuticals Ltd, Key Competitors
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Intas Pharmaceuticals Ltd, Recent Deals Summary

★海外企業調査レポート[Intas Pharmaceuticals Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ra Pharmaceuticals Inc (RARX):医療機器:M&Aディール及び事業提携情報
    Summary Ra Pharmaceuticals Inc (Ra Pharmaceuticals) is a clinical stage biopharmaceutical company that develops therapeutics for the treatment of diseases caused due to uncontrolled activation of the complement system. Ra Pharmaceuticals develops its pipeline products through its proprietary peptide …
  • TeleTech Holdings, Inc. (TTEC):企業の財務・戦略的SWOT分析
    TeleTech Holdings, Inc. (TTEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Swisscom Ltd (SCMN):企業の財務・戦略的SWOT分析
    Swisscom Ltd (SCMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Spectral Medical Inc (EDT):製薬・医療:M&Aディール及び事業提携情報
    Summary Spectral Medical Inc (Spectral), formerly Spectral Diagnostics Inc, is a biotechnology company that develops and commercializes diagnostic solutions for patient management. The company’s products comprise EAA, toraymyxin and reagents, among others. Its EAA is an endotoxin activity assay, whi …
  • W. L. Gore & Associates Inc:企業の製品パイプライン分析
    Summary W. L. Gore & Associates Inc (Gore) is a materials science company serving diverse industries. Its product portfolio includes consumer products, cables, electronic components, fabrics, fibers, medical, pharmaceutical, sealing and vents. The company develops products for medical implants; fabr …
  • Ingosstrakh Joint-Stock Insurance Company Ltd.:企業の戦略・SWOT・財務分析
    Ingosstrakh Joint-Stock Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ingosstrakh Joint-Stock Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • St. Mary’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary St. Mary's Hospital (St. Mary's), a subsidiary of MedStar Health is a healthcare service provider that offers inpatient and outpatient treatment and diagnostic services. The hospital’s services include cardiac, emergency services, family birth, geriatric, neuroscience, oncology, orthopedics, …
  • Riemser Pharma GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a healthcare products provider that markets and sells lifecycle management products. The company offers analgesics, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. Its products inc …
  • Apotex Inc:企業の戦略的SWOT分析
    Apotex Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析
    Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hoag Hospital Foundation:企業の戦略的SWOT分析
    Hoag Hospital Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • PromptCare Inc-医療機器分野:企業M&A・提携分析
    Summary PromptCare Inc (PromptCare) is a healthcare center that respiratory products and home infusion services. The center provides respiratory services such as clinical support programs, patient-focused technology and testimonials. It provides home infusion therapies for patients of all ages with …
  • AMETEK, Inc.:企業の戦略・SWOT・財務情報
    AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMETEK, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • China Gas Holdings Ltd (384):電力:M&Aディール及び事業提携情報
    Summary China Gas Holdings Ltd (CGHL) is a gas operator and service provider. The company offers piped natural gas, compressed natural gas, liquid petroleum gas and liquefied natural gas. Its activities include construction and operation of gas stations, gas pipeline infrastructure facilities, gas t …
  • The Swatch Group Ltd:企業の戦略・SWOT・財務情報
    The Swatch Group Ltd - Strategy, SWOT and Corporate Finance Report Summary The Swatch Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Concept Packaging Group:企業の戦略・SWOT・財務分析
    Concept Packaging Group - Strategy, SWOT and Corporate Finance Report Summary Concept Packaging Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Vietnam National Petroleum Group (PLX):企業の財務・戦略的SWOT分析
    Vietnam National Petroleum Group (PLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • National Power Corporation:電力:M&Aディール及び事業提携情報
    Summary National Power Corporation (Napocor) is a government owned utility. It develops hydroelectric generation plants; produces power from nuclear, geothermal, and other sources; and transmits electricity across the country. The corporation preserves and protects the dams and watershed. Napocor’s …
  • Color Genomics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Color Genomics, Inc. (Color) provides physician ordered genetic testing service that helps to identify hereditary cancer risk. The company’s clinical grade test provides actionable results that enable consumers and their doctors to create personalized screening and healthcare plan. Color ana …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆